Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ambiq Micro, Inc.AMBQ · Entity 751 | Director | June 08, 2026 | June 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ambiq Micro, Inc.
Report date June 08, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 53,703 |
Reported balance
After 2026-06-08 transaction · row 1
1 source rowRow 1 · 2026-06-08 · Grant · Acquired 4,957 · Balance 53,703 F1: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in three equal annual installments following the date of grant, with each annual RSU vesting to occur on the earlier of: (i) the first, second, or third anniversary of the grant date, as applicable, or (ii) the date of the Company's first, second, or third annual stockholder meeting following the grant date, as applicable (or the date immediately prior to the applicable annual stockholder meeting if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election), subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in three equal annual installments following the date of grant, with each annual RSU vesting to occur on the earlier of: (i) the first, second, or third anniversary of the grant date, as applicable, or (ii) the date of the Company's first, second, or third annual stockholder meeting following the grant date, as applicable (or the date immediately prior to the applicable annual stockholder meeting if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election), subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan).
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CDK Global, Inc.
Report date July 06, 2022 · Filed July 06, 2022
Section 16 reporting ended · disclosed 2022-07-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-07-06 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-07-06 · Grant · Acquired 103,073 · Balance 231,834 F1: Represents shares of common stock, par value $0.01 per share (each, a "Share"), of CDK Global, Inc. (the "Company") that are subject to performance-based restricted stock units ("PSUs"). Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022 (the "Closing Date"), Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and each PSU outstanding immediately prior to the consummation of the Merger became fully vested at the greater of the target and actual performance measured through the Closing Date (with the performance in respect of any fiscal year commencing after the 2022 fiscal year being at target performance), and was canceled and converted into the right to receive, for each Share subject to such then-vested PSU, $54.87 in cash without interest. Row 2 · 2022-07-06 · Disposition to issuer · Disposed 231,834 · Balance 0 F2: Pursuant to the Merger Agreement, at the effective time of the Merger, each Share was canceled and converted into the right to receive $54.87 in cash without interest. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $62.03 | Direct | 0 |
Reported balance
After 2022-07-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-07-06 · Disposition to issuer · Disposed 24,920 · Balance 0 F3: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock, par value $0.01 per share (each, a "Share"), of CDK Global, Inc. (the "Company") that are subject to performance-based restricted stock units ("PSUs"). Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022 (the "Closing Date"), Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and each PSU outstanding immediately prior to the consummation of the Merger became fully vested at the greater of the target and actual performance measured through the Closing Date (with the performance in respect of any fiscal year commencing after the 2022 fiscal year being at target performance), and was canceled and converted into the right to receive, for each Share subject to such then-vested PSU, $54.87 in cash without interest.
F2: Pursuant to the Merger Agreement, at the effective time of the Merger, each Share was canceled and converted into the right to receive $54.87 in cash without interest.
F3: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2026 Filed Jun 10, 2026 20:43 UTC | Ambiq Micro, Inc. AMBQ · Entity 751 | GrantCommon Stock | 4,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001482249-26-000004 · form4-06102026_080655.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,703 F1 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in three equal annual installments following the date of grant, with each annual RSU vesting to occur on the earlier of: (i) the first, second, or third anniversary of the grant date, as applicable, or (ii) the date of the Company's first, second, or third annual stockholder meeting following the grant date, as applicable (or the date immediately prior to the applicable annual stockholder meeting if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election), subject to the Reporting Person's Continuous Service (as defined in the Issuer's 2025 Equity Incentive Plan). Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 23:15 UTC | Ambiq Micro, Inc. AMBQ · Entity 751 | SaleCommon Stock | 7,800 | $31.00 | $241,800.00 |
DisclosureSEC source: 0001482249-26-000002 · form4-01282026_110143.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,746 Read SEC document |
| July 29, 2025 Filed Jul 31, 2025 22:14 UTC | Ambiq Micro, Inc. AMBQ · Entity 751 | GrantCommon Stock | 56,546 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-020772 · form4-07312025_100701.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,546 F1 · shares: Consists of previously granted restricted stock units ("RSUs") for which the liquidity event-based vesting condition was satisfied upon the effectiveness of the registration statement on Form S-1 filed by the Issuer in connection with the Issuer's initial public offering. The RSUs remain subject to service-based vesting conditions. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 23:31 UTC | CDK Global, Inc. CDK · Entity 125554 | Disposition to issuerOption (right to buy) · Derivative | 24,920 | Not disclosed Strike: $62.03 | Not disclosed |
DisclosureSEC source: 0000950142-22-002141 · es220267549_4-tautges.xml · derivative · entry 3 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,920 shares Expires not disclosed F3 · price: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0. F3 · derivative.expiration_date: Pursuant to the Merger Agreement, each option outstanding immediately prior to the consummation of the Merger, whether then unvested or vested, by virtue of the Merger and without any action by the holder, was canceled and converted into only the right to receive an amount in cash, without interest, equal to the product of (x) the number of Shares issuable under such option and (y) the excess, if any, of (i) $54.87 over (ii) the exercise price payable in respect of each Share issuable under such option (the "Option Consideration"); provided, however, that the Option Consideration for each option with an exercise price equal to or greater than $54.87 was $0. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 23:31 UTC | CDK Global, Inc. CDK · Entity 125554 | Disposition to issuerCommon Stock | 231,834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-22-002141 · es220267549_4-tautges.xml · nonDerivative · entry 2 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: Pursuant to the Merger Agreement, at the effective time of the Merger, each Share was canceled and converted into the right to receive $54.87 in cash without interest. Read SEC document |
| July 06, 2022 Filed Jul 6, 2022 23:31 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 103,073 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-22-002141 · es220267549_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,834 F1 · shares: Represents shares of common stock, par value $0.01 per share (each, a "Share"), of CDK Global, Inc. (the "Company") that are subject to performance-based restricted stock units ("PSUs"). Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022 (the "Closing Date"), Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and each PSU outstanding immediately prior to the consummation of the Merger became fully vested at the greater of the target and actual performance measured through the Closing Date (with the performance in respect of any fiscal year commencing after the 2022 fiscal year being at target performance), and was canceled and converted into the right to receive, for each Share subject to such then-vested PSU, $54.87 in cash without interest. F1 · price: Represents shares of common stock, par value $0.01 per share (each, a "Share"), of CDK Global, Inc. (the "Company") that are subject to performance-based restricted stock units ("PSUs"). Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), among the Company, Central Parent LLC ("Parent") and Central Merger Sub Inc. ("Merger Sub"), on July 6, 2022 (the "Closing Date"), Merger Sub merged with and into the Company, with the Company surviving the merger as a wholly owned subsidiary of Parent (the "Merger"), and each PSU outstanding immediately prior to the consummation of the Merger became fully vested at the greater of the target and actual performance measured through the Closing Date (with the performance in respect of any fiscal year commencing after the 2022 fiscal year being at target performance), and was canceled and converted into the right to receive, for each Share subject to such then-vested PSU, $54.87 in cash without interest. Read SEC document |
| September 17, 2021 Filed Sep 20, 2021 22:34 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 9,129 | $42.35 | $386,613.15 |
DisclosureSEC source: 0000950142-21-002954 · es210185401_4-tautges.xml · nonDerivative · entry 2 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,761 Read SEC document |
| September 16, 2021 Filed Sep 20, 2021 22:34 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 45,785 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-21-002954 · es210185401_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,890 F1 · price: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan and represents a like number of shares of the Issuer's common stock. These Restricted Stock Units vest in three equal installments on September 16, 2022, September 12, 2023, and September 12, 2024. Upon vesting these Restricted Stock Units will settle in shares of the Issuer's common stock. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 22:37 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 2,367 | $42.43 | $100,431.81 |
DisclosureSEC source: 0000950142-21-002903 · es210184044_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,105 Read SEC document |
| September 03, 2021 Filed Sep 7, 2021 22:31 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 1,222 | $41.14 | $50,273.08 |
DisclosureSEC source: 0000950142-21-002828 · es210182583_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,472 Read SEC document |
| August 26, 2021 Filed Aug 30, 2021 22:39 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 5,852 | $40.97 | $239,756.44 |
DisclosureSEC source: 0000950142-21-002775 · es210181050_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,694 Read SEC document |
| August 13, 2021 Filed Aug 18, 2021 00:32 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 11,803 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-21-002665 · es210178233_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,546 Read SEC document |
| September 17, 2020 Filed Sep 21, 2020 22:34 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 55,235 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-20-002291 · es200101490_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,743 F1 · price: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan and represents a like number of shares of the Issuer's common stock. These Restricted Stock Units vest in three equal installments on September 17, 2021, September 17, 2022, and September 17, 2023. Upon vesting these Restricted Stock Units will settle in shares of the Issuer's common stock. Read SEC document |
| September 11, 2020 Filed Sep 15, 2020 22:34 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 2,562 | $43.83 | $112,292.46 |
DisclosureSEC source: 0000950142-20-002235 · es2001169_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,508 Read SEC document |
| September 04, 2020 Filed Sep 8, 2020 22:02 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 1,322 | $45.41 | $60,032.02 |
DisclosureSEC source: 0000950142-20-002183 · es2001142_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,070 Read SEC document |
| August 27, 2020 Filed Aug 31, 2020 22:34 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 4,072 | $46.64 | $189,918.08 |
DisclosureSEC source: 0000950142-20-002129 · es2001119_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,392 Read SEC document |
| August 07, 2020 Filed Aug 10, 2020 22:37 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 2,163 | $46.89 | $101,423.07 |
DisclosureSEC source: 0000950142-20-001976 · es2001050_4-tautges.xml · nonDerivative · entry 2 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,464 Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 22:37 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 7,589 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-20-001976 · es2001050_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,627 Read SEC document |
| September 12, 2019 Filed Sep 17, 2019 00:00 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 14,322 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-19-001973 · es1901101_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,038 F1 · price: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan and represents a like number of shares of the Issuer's common stock. These Restricted Stock Units vest in three equal installments on September 11, 2020, September 10, 2021, and September 12, 2022. Upon vesting these Restricted Stock Units will settle in shares of the Issuer's common stock. Read SEC document |
| September 06, 2019 Filed Sep 10, 2019 23:55 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 1,092 | $44.92 | $49,052.64 |
DisclosureSEC source: 0000950142-19-001937 · es1901082_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,716 Read SEC document |
| August 08, 2019 Filed Aug 12, 2019 23:31 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 1,786 | $49.71 | $88,782.06 |
DisclosureSEC source: 0000950142-19-001756 · es1901004_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,808 Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 23:05 UTC | CDK Global, Inc. CDK · Entity 125554 | PurchaseCommon Stock | 7,900 | $50.68 | $400,355.41 |
DisclosureSEC source: 0000950142-18-002203 · es1801211_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,594 F1 · price: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple open market transactions at prices ranging from $50.60 to $50.68, inclusive. The reporting person undertakes to provide to CDK Global, Inc., a security holder thereof, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote (1). Read SEC document |
| September 06, 2018 Filed Sep 10, 2018 23:30 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 7,390 | $60.89 | $449,977.10 |
DisclosureSEC source: 0000950142-18-001865 · es1801048_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,694 F1 · security: The reported transaction reflects the grant of Restricted Stock Units under the Issuer's 2014 Omnibus Award Plan and represents a like number of shares of the Issuer's common stock. These Restricted Stock Units vest in three equal installments on September 6, 2019, 2020 and 2021. Upon vesting these Restricted Stock Units will settle in shares of the Issuer's common stock. Read SEC document |
| August 08, 2018 Filed Aug 9, 2018 23:03 UTC | CDK Global, Inc. CDK · Entity 125554 | Tax withholdingCommon Stock | 1,786 | $64.20 | $114,661.20 |
DisclosureSEC source: 0000950142-18-001730 · es1800973_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,304 Read SEC document |
| August 08, 2017 Filed Aug 11, 2017 00:13 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantStock Option (Right to Buy) · Derivative | 24,920 | $0.00 Strike: $62.03 | $0.00 |
DisclosureSEC source: 0000950142-17-001503 · es1700878_4-tautges.xml · derivative · entry 2 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,920 Underlying: Common Stock · 24,920 shares Expires 2027-08-08 F2 · derivative.exercise_date: The options become exercisable in four equal installments on September 8, 2018, 2019, 2020 and 2021. Read SEC document |
| August 08, 2017 Filed Aug 11, 2017 00:13 UTC | CDK Global, Inc. CDK · Entity 125554 | GrantCommon Stock | 12,090 | $0.00 | $0.00 |
DisclosureSEC source: 0000950142-17-001503 · es1700878_4-tautges.xml · nonDerivative · entry 1 TAUTGES JOSEPH A · CIK 0001482249 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,090 F1 · price: The reported transaction reflects the grant of Restricted Stock under the Issuer's 2014 Omnibus Award Plan. The Restricted Stock vests in three equal installments on August 8, 2018, 2019, and 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.